CL6 Stock Overview
Operates as a recruitment and staffing company in the healthcare, life science, and social work industry in Sweden, Norway, Finland, the United Kingdom, and Denmark.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 3/6 |
Past Performance | 3/6 |
Financial Health | 5/6 |
Dividends | 5/6 |
Dedicare AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr5.00 |
52 Week High | kr11.06 |
52 Week Low | kr4.68 |
Beta | 0.82 |
1 Month Change | -42.13% |
3 Month Change | -40.83% |
1 Year Change | -54.30% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -57.41% |
Recent News & Updates
Recent updates
Shareholder Returns
CL6 | DE Healthcare | DE Market | |
---|---|---|---|
7D | 1.4% | 3.6% | 1.6% |
1Y | -54.3% | 1.6% | 7.3% |
Return vs Industry: CL6 underperformed the German Healthcare industry which returned -0.9% over the past year.
Return vs Market: CL6 underperformed the German Market which returned 6.5% over the past year.
Price Volatility
CL6 volatility | |
---|---|
CL6 Average Weekly Movement | 10.6% |
Healthcare Industry Average Movement | 6.5% |
Market Average Movement | 5.0% |
10% most volatile stocks in DE Market | 10.6% |
10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: CL6's share price has been volatile over the past 3 months.
Volatility Over Time: CL6's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1995 | 1,106 | Krister Widstrom | www.dedicare.se |
Dedicare AB (publ) operates as a recruitment and staffing company in the healthcare, life science, and social work industry in Sweden, Norway, Finland, the United Kingdom, and Denmark. It recruits and contracts doctors, nurses, social workers, sociologists, psychologists, preschool staff, and life science specialists. The company was incorporated in 1995 and is headquartered in Stockholm, Sweden.
Dedicare AB (publ) Fundamentals Summary
CL6 fundamental statistics | |
---|---|
Market cap | €48.53m |
Earnings (TTM) | €8.31m |
Revenue (TTM) | €163.67m |
5.8x
P/E Ratio0.3x
P/S RatioIs CL6 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CL6 income statement (TTM) | |
---|---|
Revenue | kr1.90b |
Cost of Revenue | kr1.57b |
Gross Profit | kr324.67m |
Other Expenses | kr228.27m |
Earnings | kr96.40m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 12, 2024
Earnings per share (EPS) | 10.08 |
Gross Margin | 17.09% |
Net Profit Margin | 5.07% |
Debt/Equity Ratio | 4.7% |
How did CL6 perform over the long term?
See historical performance and comparison